BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34934970)

  • 1. Prostate Cancer-specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users.
    Joentausta RM; Rannikko A; Murtola TJ
    Eur Urol Open Sci; 2021 Dec; 34():86-93. PubMed ID: 34934970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor features and survival after radical prostatectomy among antidiabetic drug users.
    Joentausta RM; Kujala PM; Visakorpi T; Tammela TL; Murtola TJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):367-373. PubMed ID: 27502739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic Drugs and Prostate Cancer Prognosis in a Finnish Population-Based Cohort.
    Vihervuori VJ; Talala K; Taari K; Lahtela J; Tammela TLJ; Auvinen A; Raittinen P; Murtola TJ
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):982-989. PubMed ID: 33653815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.
    Santala EE; Rannikko A; Murtola TJ
    Int J Cancer; 2019 Feb; 144(3):440-447. PubMed ID: 30110124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study.
    Lee YHA; Hui JMH; Chan JSK; Liu K; Dee EC; Ng K; Tang P; Tse G; Ng CF
    Prostate; 2023 Jan; 83(1):119-127. PubMed ID: 36178848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiabetic drugs influence molecular mechanisms in prostate cancer.
    Pircher A; Zieher M; Eigentler A; Pichler R; Schäfer G; Fritz J; Puhr M; Steiner E; Horninger W; Klocker H; Heidegger I
    Cancer Biol Ther; 2018; 19(12):1153-1161. PubMed ID: 30067448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of prostate cancer screening among men using antidiabetic medication.
    Vettenranta A; Murtola TJ; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    Sci Rep; 2021 Apr; 11(1):7363. PubMed ID: 33795720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
    Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin.
    Murtola TJ; Wahlfors T; Haring A; Taari K; Stenman UH; Tammela TL; ; Schleutker J; Auvinen A
    Eur Urol; 2015 Dec; 68(6):1089-97. PubMed ID: 25819720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Peltomaa AI; Talala K; Määttänen L; Taari K; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2017 Apr; 3(2-3):212-220. PubMed ID: 28753762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer.
    Murtola TJ; Sälli SM; Talala K; Taari K; Tammela TLJ; Auvinen A
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):453-460. PubMed ID: 30679762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
    Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
    Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
    Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
    JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.
    Yang DD; Mahal BA; Muralidhar V; Martin NE; Orio PF; Mouw KW; King MT; Choueiri TK; Trinh QD; Hoffman KE; Spratt DE; Feng FY; Nguyen PL
    Eur Urol; 2019 Jan; 75(1):35-41. PubMed ID: 30554605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased tumor-associated macrophages in the prostate cancer microenvironment predicted patients' survival and responses to androgen deprivation therapies in Indonesian patients cohort.
    Yuri P; Shigemura K; Kitagawa K; Hadibrata E; Risan M; Zulfiqqar A; Soeroharjo I; Hendri AZ; Danarto R; Ishii A; Yamasaki S; Yan Y; Heriyanto DS; Fujisawa M
    Prostate Int; 2020 Jun; 8(2):62-69. PubMed ID: 32647642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC; Schipper MJ; Johnson SB; Foster C; Li D; Sandler HM; Palapattu GS; Hamstra DA; Feng FY
    Eur Urol; 2016 Jan; 69(1):50-7. PubMed ID: 26004800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.